Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Osteoclasts are the primary mediators of pathological bone resorption in many conditions in which micro‐environmental hypoxia is associated with disease progression. However, effects of hypoxia on human osteoclast activity have not been reported. Mature human osteoclasts were differentiated from peripheral blood or obtained from giant cell tumour of bone. Osteoclasts were exposed to a constant hypoxic environment and then assessed for parameters including resorption (toluidine blue staining of dentine slices), membrane integrity (trypan blue exclusion), apoptosis (TUNEL, DAPI), and osteolysis‐associated enzyme activity (TRAP, cathepsin K). 24 h exposure to 2% O 2 produced a 2.5‐fold increase in resorption associated with increased TRAP and cathepsin K enzyme activity. Hypoxia‐Inducible Factor‐1α (HIF‐1α) siRNA completely ablated the hypoxic increase in osteoclast resorption. 24 h at 2% O 2 also increased the number of osteoclasts with compromised membrane integrity from 6% to 21%, with no change in the total osteoclast number or the proportion of late‐stage apoptotic cells. Transient reoxygenation returned the percentage of trypan blue‐positive cells to normoxic levels, suggesting that osteoclasts can recover from the early stages of cell death. Repeated over an extended period, hypoxia/reoxygenation enhanced osteoclast differentiation at this p O 2 . These data suggest that in diseased bone, where the p O 2 may fall to ≤2% O 2 , a delicate balance between hypoxia‐induced osteoclast activation and hypoxia‐induced osteoclast apoptosis mediates pathological bone resorption. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“The HIF transcriptional cascade includes pathways encompassing angiogenesis, apoptosis, glycolysis and pH regulation — processes central to cell survival and expansion in an oxygen-deficient environment [10].”
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity
Gordan, J. D., Bertout, J. A., Hu, C.-J., Diehl, J. A., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.006 · Cited by 781
Hiraga, T., Kizaka-Kondoh, S., Hirota, K., Hiraoka, M., & Yoneda, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2355 · Cited by 242 · cited 2×
“Overexpression of a constitutively active form of HIF-1α inhibited in vitro osteoblastic differentiation [4].”
Cited by
An overview of the regulation of bone remodelling at the cellular level
Kular, J., Tickner, J., Chim, S. M., & Xu, J. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.03.021 · Cited by 534
Arnett, T. R. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.07.021 · Cited by 265
Energy metabolism in osteoclast formation and activity
Lemma, S., Sboarina, M., Porporato, P. E., Zini, N., Sonveaux, P., Di Pompo, G., Baldini, N., & Avnet, S. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.08.034 · Cited by 222
“Notably, hypoxia reduces the viability of mature osteoclasts, thereby suggesting that OxPhos supports osteoclast survival (Arnett, 2010, Knowles and Athanasou, 2009).”
BackgroundDunn, L. K., Mohammad, K. S., Fournier, P. G. J., McKenna, C. R., Davis, H. W., Niewolna, M., Peng, X. H., Chirgwin, J. M., & Guise, T. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006896 · Cited by 212
“In addition, HIF-1a also regulates osteoclast formation and bone resorption [63,64] by increasing VEGF expression which substitutes for M-CSF to promote osteoclastogenesis together with RANKL [65,66].”
BackgroundAutophagy regulates hypoxia‐induced osteoclastogenesis through the HIF‐1α/BNIP3 signaling pathway
Zhao, Y., Chen, G., Zhang, W., Xu, N., Zhu, J., Jia, J., Sun, Z., Wang, Y., & Zhao, Y. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22768 · Cited by 156
Metadata
- Authors
- Knowles, H. J., & Athanasou, N. A.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2009-03-16
- Volume
- 218
- Issue
- 2
- Pages
- 256-264
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2048149512
- Cited by
- 116
- References
- 6
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.